It has been demonstrated that the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway plays a critical role in the initiation and development of several cancers and could therefore be a therapeutic target in cancer treatment. This evidence concerns the gene AKT1 and cancer.